ArticleHeliyon2023
COVID-19 retracted publications on retraction watch: A systematic survey of their pre-prints and citations.
Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The importance of rigor in pharmacy research: Challenges and solutions.Research in social & administrative pharmacy : RSAP · 2025Article
- Understanding stigma of dementia during COVID-19: a scoping review.Frontiers in psychiatry · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Studies related to the coronavirus disease 2019 (COVID-19) were frequently published as pre-prints prior to undergoing peer-review. However, several publications were later retracted due to ethical concerns or study misconduct. Although these studies have been retracted, the availability of their corresponding pre-prints has never been formally investigated, and may result in the spread of misinformation if they are being used to inform decision-making. Methods: Our objective was to conduct a systematic survey of retracted COVID-19 publications listed on the Retraction Watch database as of August 15th, 2021. We assessed the availability of corresponding pre-prints for retracted publications, and documented the number of citations and online views. Results: Our study included 140 retracted COVID-19 publications, and we could not retrieve corresponding pre-prints for 132 retracted publications in our study (94%). Although we were unable to find the majority of pre-prints, they had already been disseminated, with a maximal citation count of 593 and Altmetric score of 558,928. Conclusion: While it is reassuring that most corresponding pre-prints could not be retrieved, our study highlights the need for online platforms and journals to employ quality assurance methods to prevent the spread of misinformation through citation of retracted papers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.